{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:52:47Z","timestamp":1761864767490,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"DOI":"10.7759\/cureus.92172","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:38:18Z","timestamp":1757713098000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapid Enlargement of Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa During Bimekizumab Therapy"],"prefix":"10.7759","author":[{"given":"Yuto","family":"Yamamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyasu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisa","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication","volume":"27","author":"Chapman S","year":"2018","unstructured":"Chapman S, Delgadillo D II, Barber C, Khachemoune A. Cutaneous squamous cell carcinoma complicating hidradenitis suppurativa: a review of the prevalence, pathogenesis, and treatment of this dreaded complication. Acta Dermatovenerol Alp Pannonica Adriat. 2018, 27:25-8.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/000313480807401209","article-title":"Hidradenitis suppurativa complicated by squamous cell carcinoma","volume":"74","author":"Constantinou C","year":"2008","unstructured":"Constantinou C, Widom K, Desantis J, Obmann M. Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg. 2008, 74:1177-81. 10.1177\/000313480807401209","journal-title":"Am Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20472","article-title":"European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment","volume":"39","author":"Zouboulis CC","year":"2025","unstructured":"Zouboulis CC, Bechara FG, Benhadou F, et al.. European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment. J Eur Acad Dermatol Venereol. 2025, 39:899-941. 10.1111\/jdv.20472","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2024.06.006","article-title":"The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review","volume":"17","author":"Vangilbergen M","year":"2024","unstructured":"Vangilbergen M, Stockman A, Van De Velde A, Garmyn M, Punie K, Hillary T. The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: a systematic review. JAAD Int. 2024, 17:71-9. 10.1016\/j.jdin.2024.06.006","journal-title":"JAAD Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5070\/d3203021764","article-title":"A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma","volume":"20","author":"Scheinfeld N","year":"2014","unstructured":"Scheinfeld N. A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma. Dermatol Online J. 2014, 20:17. 10.5070\/d3203021764","journal-title":"Dermatol Online J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball AB","year":"2024","unstructured":"Kimball AB, Jemec GB, Sayed CJ, et al.. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials. Lancet. 2024, 403:2504-19. 10.1016\/S0140-6736(24)00101-6","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051153","article-title":"Cutaneous squamous cell carcinoma in patients with hidradenitis suppurativa","volume":"13","author":"Racanelli E","year":"2021","unstructured":"Racanelli E, Jfri A, Gefri A, et al.. Cutaneous squamous cell carcinoma in patients with hidradenitis suppurativa. Cancers (Basel). 2021, 13:1153. 10.3390\/cancers13051153","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2382372","article-title":"A state-of-the-art systematic review of cancer in hidradenitis suppurativa","volume":"56","author":"Abu Rached N","year":"2024","unstructured":"Abu Rached N, R\u00fcth J, Gambichler T, Ocker L, Bechara FG. A state-of-the-art systematic review of cancer in hidradenitis suppurativa. Ann Med. 2024, 56:2382372. 10.1080\/07853890.2024.2382372","journal-title":"Ann Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.26182","article-title":"Increased cancer incidence among patients with hidradenitis suppurativa - a Danish nationwide register study 1977-2017","volume":"63","author":"Andersen R","year":"2024","unstructured":"Andersen R, Rostgaard K, Pedersen O, Jemec GB, Hjalgrim H. Increased cancer incidence among patients with hidradenitis suppurativa - a Danish nationwide register study 1977-2017. Acta Oncol. 2024, 63:220-8. 10.2340\/1651-226X.2024.26182","journal-title":"Acta Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111594","article-title":"Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments","volume":"9","author":"Li Pomi F","year":"2021","unstructured":"Li Pomi F, Macca L, Motolese A, Ingrasciotta Y, Berretta M, Guarneri C. Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments. Biomedicines. 2021, 9:1594. 10.3390\/biomedicines9111594","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1479505","article-title":"The role of interleukin-17 in inflammation-related cancers","volume":"15","author":"Zhang X","year":"2024","unstructured":"Zhang X, Li B, Lan T, Chiari C, Ye X, Wang K, Chen J. The role of interleukin-17 in inflammation-related cancers. Front Immunol. 2024, 15:1479505. 10.3389\/fimmu.2024.1479505","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19520","article-title":"Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-insights from an international population-based study","volume":"38","author":"Kridin K","year":"2024","unstructured":"Kridin K, Abdelghaffar M, Mruwat N, Ludwig RJ, Tha\u00e7i D. Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-insights from an international population-based study. J Eur Acad Dermatol Venereol. 2024, 38:315-24. 10.1111\/jdv.19520","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2261326","article-title":"Interleukin-17 signaling influences CD8(+) T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells","volume":"12","author":"Rodriguez C","year":"2023","unstructured":"Rodriguez C, Araujo Furlan CL, Tosello Boari J, et al.. Interleukin-17 signaling influences CD8(+) T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells. Oncoimmunology. 2023, 12:2261326. 10.1080\/2162402X.2023.2261326","journal-title":"Oncoimmunology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0775","article-title":"IL-17 enhances tumor development in carcinogen-induced skin cancer","volume":"70","author":"Wang L","year":"2010","unstructured":"Wang L, Yi T, Zhang W, Pardoll DM, Yu H. IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res. 2010, 70:10112-20. 10.1158\/0008-5472.CAN-10-0775","journal-title":"Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408685-rapid-enlargement-of-squamous-cell-carcinoma-arising-from-hidradenitis-suppurativa-during-bimekizumab-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:38:19Z","timestamp":1757713099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408685-rapid-enlargement-of-squamous-cell-carcinoma-arising-from-hidradenitis-suppurativa-during-bimekizumab-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.92172","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]}}}